Evidence map›Paper›PMID 38774436›Full record

ArticleFrontiers in psychiatry2024

Stimulant medication use and apparent cortical thickness development in attention-deficit/hyperactivity disorder: a prospective longitudinal study.

Zarah van der Pal, Kristine B Walhovd, Inge K Amlien, Carlijn Jamila Guichelaar, Antonia Kaiser, Marco A Bottelier, Hilde M Geurts, Liesbeth Reneman, Anouk Schrantee

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zarah van der PalDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center (UMC) location University of Amsterdam, Amsterdam, Netherlands.
Kristine B WalhovdDepartment of Psychology, University of Oslo, Oslo, Norway.
Inge K AmlienDepartment of Psychology, University of Oslo, Oslo, Norway.
Carlijn Jamila GuichelaarDepartment of Psychology, University of Oslo, Oslo, Norway.
Antonia KaiserDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center (UMC) location University of Amsterdam, Amsterdam, Netherlands.
Marco A BottelierAccare, Centre for Academic Child and Adolescent Psychiatry, University Medical Center (UMC) Groningen, Groningen, Netherlands.
Hilde M GeurtsDivision of Brain & Cognition, Department of Psychology, University of Amsterdam, Amsterdam, Netherlands.
Liesbeth RenemanDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center (UMC) location University of Amsterdam, Amsterdam, Netherlands.
Anouk SchranteeDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center (UMC) location University of Amsterdam, Amsterdam, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Stimulant medication is commonly prescribed as treatment for attention-deficit/hyperactivity disorder (ADHD). While we previously found that short-term stimulant-treatment influences apparent cortical thickness development in an age-dependent manner, it remains unknown whether these effects persist throughout development into adulthood. Purpose: Investigate the long-term age-dependent effects of stimulant medication use on apparent cortical thickness development in adolescents and adults previously diagnosed with ADHD. Methods: This prospective study included the baseline and 4-year follow-up assessment of the "effects of Psychotropic drugs On the Developing brain-MPH" ("ePOD-MPH") project, conducted between June-1-2011 and December-28-2019. The analyses were pre-registered (https://doi.org/10.17605/OSF.IO/32BHF). T1-weighted MR scans were obtained from male adolescents and adults, and cortical thickness was estimated for predefined regions of interest (ROIs) using Freesurfer. We determined medication use and assessed symptoms of ADHD, anxiety, and depression at both time points. Linear mixed models were constructed to assess main effects and interactions of stimulant medication use, time, and age group on regional apparent cortical thickness. Results: A total of 32 male adolescents (aged mean ± SD, 11.2 ± 0.9 years at baseline) and 24 men (aged mean ± SD, 29.9 ± 5.0 years at baseline) were included that previously participated in the ePOD-MPH project. We found no evidence for long-term effects of stimulant medication use on ROI apparent cortical thickness. As expected, we did find age-by-time interaction effects in all ROIs (left prefrontal ROI: P=.002, right medial and posterior ROIs: P<.001), reflecting reductions in apparent cortical thickness in adolescents. Additionally, ADHD symptom severity (adolescents: P<.001, adults: P=.001) and anxiety symptoms (adolescents: P=0.03) were reduced, and more improvement of ADHD symptoms was associated with higher medication use in adults (P=0.001). Conclusion: We found no evidence for long-term effects of stimulant-treatment for ADHD on apparent cortical thickness development in adolescents and adults. The identified age-dependent differences in apparent cortical thickness development are consistent with existing literature on typical cortical development.

Indexed as

attention-deficit/hyperactivity disorder (ADHD)cortical developmentcortical thicknessFreeSurfergray matterstimulant medication

Identifiers

PMID38774436
PMCPMC11107082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.